1. Tunis, SR, Stryer, DB, Clancy, CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290(12): 1624–1632.
Google Scholar | Crossref | Medline | ISI2. NIH collaboratory rethinking clinical trials: the living textbook—rethinking clinical trials . https://rethinkingclinicaltrials.org/
Google Scholar3. Loudon, K, Treweek, S, Sullivan, F, et al. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015; 350: h2147–h2147.
Google Scholar | Crossref | Medline4. Sugarman, J, Califf, RM. Ethics and regulatory complexities for pragmatic clinical trials. JAMA 2014; 311: 2381–2382.
Google Scholar | Crossref | Medline | ISI5. Califf, RM, Sugarman, J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials 2015; 12(5): 436–441.
Google Scholar | SAGE Journals | ISI6. Giuffrida, A, Torgerson, DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997; 315: 703–707.
Google Scholar | Crossref | Medline7. Dickert, N, Grady, C. What’s the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999; 341: 198–203.
Google Scholar | Crossref | Medline | ISI8. Resnik, DB . Research participation and financial inducements. American J Bioeth 2001; 1: 54–56.
Google Scholar | Crossref | Medline9. Permuth-Wey, J, Borenstein, AR. Financial remuneration for clinical and behavioral research participation: ethical and practical considerations. Ann Epidemiol 2009; 19(4): 280–285.
Google Scholar | Crossref | Medline | ISI10. Tseng, J, Angelos, P. Payment to research participants. In: Itani, KMF, Reda, DJ (eds) Clinical trials design in operative and non operative invasive procedures. Cham: Springer, 2017, pp. 211–213.
Google Scholar | Crossref11. Hurley, E . Why we need to keep the term “research subject” in our research ethics vocabulary. J Clin Res Best Pract 2019; 15(2).
Google Scholar12. Gelinas, L, Largent, EA, Cohen, IG, et al. A framework for ethical payment to research participants. N Engl J Med 2018; 378: 766–771.
Google Scholar | Crossref | Medline13. Office of the Commissioner . Payment and reimbursement to research subjects. Silver Spring, MD: U.S. Food and Drug Administration, 2018.
Google Scholar14. Koen, J, Slack, C, Barsdorf, N, et al. Payment of trial participants can be ethically sound: moving past a flat rate. S Afr Med J 2008; 98(12): 926–929.
Google Scholar | Medline15. Breitkopf, CR, Loza, M, Vincent, K, et al. Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics 2011; 6(3): 31–38.
Google Scholar | SAGE Journals | ISI16. Persad, G, Fernandez Lynch, H, Largent, E. Differential payment to research participants in the same study: an ethical analysis. J Med Ethics 2019; 45(5): 318–322.
Google Scholar | Crossref | Medline17. MacKay, D, Saylor, KW. Four faces of fair subject selection. Am J Bioeth 2020; 20(2): 5–19.
Google Scholar | Crossref | Medline18. Zigler, C, Debar, L, Weinfurt, K. How are PRO measures used. In: The living textbook. NIH Collaboratory , 2017, https://rethinkingclinicaltrials.org/chapters/conduct/real-world-evidence-patient-reported-outcomes-pros/how-are-pro-measures-used/
Google Scholar19. Dember, LM, Lacson, E, Brunelli, SM, et al. The TiME Trial: a fully embedded, cluster-randomized, pragmatic trial of hemodialysis session duration. J Am Soc Nephrol 2019; 30(5): 890–903.
Google Scholar | Crossref | Medline20. Grady, C, Dickert, N, Jawetz, T, et al. An analysis of U.S. Practices of paying research participants. Contemp Clin Trials 2005; 26: 365–375.
Google Scholar | Crossref | Medline | ISI21. Ripley, E, Macrina, F, Markowitz, M, et al. Why do we pay? A national survey of investigators and IRB chairpersons. J Empir Res Hum Res Ethics 2010; 5(3): 43–56.
Google Scholar | SAGE Journals | ISI22. Ripley, E, Macrina, F, Markowitz, M, et al. Who’s doing the math. J Empir Res Hum Res Ethics 2010; 5(3): 57–65.
Google Scholar | SAGE Journals | ISI23. Grady, C . The continued complexities of paying research participants. Am J Bioeth 2019; 19(9): 5–7.
Google Scholar | Crossref | Medline24. Okta . The cost of privacy. https://www.okta.com/cost-of-privacy-report/2020
Google Scholar25. Groth, O, Straube, T. Personal data is valuable: give pricing power to the people. Wired, 2020, https://www.wired.com/story/opinion-give-data-pricing-power-to-the-people/
Google Scholar26. Malgieri, G, Custers, B. Pricing privacy the right to know the value of your personal data. Comput Law Sec Rev 2018; 34: 289–303.
Google Scholar | Crossref27. King, NMP . Defining and describing benefit appropriately in clinical trials. J Law Med Ethics 2000; 28(4): 332–343.
Google Scholar | SAGE Journals | ISI28. Weinfurt, KP, Bollinger, JM, Brelsford, KM, et al. Patients’ views concerning research on medical practices: implications for consent. AJOB Empir Bioeth 2016; 7(2): 76–91.
Google Scholar | Crossref | Medline29. Weinfurt, KP, Bollinger, JM, Brelsford, KM, et al. Comparison of approaches for notification and authorization in pragmatic clinical research evaluating commonly used medical practices. Med Care 2017; 55(11): 970–978.
Google Scholar | Crossref | Medline30. Bollinger, JM, Geller, G, Weinfurt, K, et al. Patients’ views about the disclosure of collateral findings in pragmatic clinical trials: a focus group study. J Gen Intern Med 2020; 35(12): 3436–3442.
Google Scholar | Crossref | Medline31. Macklin, R . “Due” and “undue” inducements: on paying money to research subjects. IRB 1981; 3: 1–6.
Google Scholar | Crossref | Medline32. Ackerman, TF . An ethical framework for the practice of paying research subjects. IRB 1989; 11(4): 1–4.
Google Scholar | Crossref | Medline33. Grady, C . Money for research participation: does it jeopardize informed consent? Am J Bioeth 2001; 1: 40–44.
Google Scholar | Crossref | Medline34. Heath, E . On considering (what I might do for) money. Am J Bioeth 2001; 1: 63–64.
Google Scholar | Crossref | Medline35. Emanuel, EJ . Undue inducement: nonsense on stilts. Am J Bioeth 2005; 5(5): 9–13; discussion W8.
Google Scholar | Crossref | Medline | ISI36. VanderWalde, A . Undue inducement: the only objection to payment. Am J Bioeth 2005; 5(5): 25–27.
Google Scholar | Crossref | Medline37. Devine, EG, Knapp, CM, Sarid-Segal, O, et al. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemp Clin Trials 2015; 41: 55–61.
Google Scholar | Crossref | Medline38. Murray, TH . Gifts of the body and the needs of strangers. Hastings Cent Rep 1987; 17(2): 30–38.
Google Scholar | Crossref | Medline39. Savulescu, J . On the commercial exploitation of participants of research. J Med Ethics 1997; 23(6): 392.
Google Scholar | Crossref | Medline40. Bentley, JP, Thacker, PG. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics 2004; 30(3): 293–298.
Google Scholar | Crossref | Medline | ISI41. Largent, EA, Lynch, HF. Paying research participants: the outsized influence of “undue influence.” IRB 2017; 39: 1–9.
Google Scholar | Medline42. Menikoff, J . Just compensation: paying research subjects relative to the risks they bear. Am J Bioeth 2001; 1: 56–58.
Google Scholar | Crossref | Medline43. Grant, RW, Sugarman, J. Ethics in human subjects research: do incentives matter. J Med Philos 2004; 29(6): 717–738.
Google Scholar | Crossref | Medline | ISI44. Chen, SC, Kim, SY. A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials. Clin Trials 2016; 13(6): 605–611.
Google Scholar | SAGE Journals | ISI45. Heyman, J, Ariely, D. Effort for payment: a tale of two markets. Psychol Sci 2004; 15: 787–793.
Google Scholar | SAGE Journals | ISI46. Largent, EA, Joffe, S, Miller, FG. Can RESEARCH and CARE be ethically integrated? Hastings Cent Rep 2011; 41(4): 37–46.
Google Scholar | Crossref | Medline